S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(1.45%) $922.85
USD/EUR
(0.04%) $0.927
USD/NOK
(0.15%) $10.86
USD/GBP
(0.00%) $0.792
USD/RUB
(0.12%) $92.55

实时更新: PCI Biotech Holding ASA [PCIB.OL]

交易所: OSE 部门: Biotechnology 工业: Biotechnology
最后更新时间27 Mar 2024 @ 19:53

3.03% NOK 1.698

Live Chart Being Loaded With Signals

Commentary (27 Mar 2024 @ 19:53):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform...

Stats
今日成交量 19 672.00
平均成交量 145 113
市值 63.38M
EPS NOK0 ( 2024-02-14 )
下一个收益日期 ( NOK0 ) 2024-05-09
Last Dividend NOK0 ( N/A )
Next Dividend NOK0 ( N/A )
P/E -2.15
ATR14 NOK0.0200 (1.18%)

PCI Biotech Holding ASA 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

PCI Biotech Holding ASA 财务报表

Annual 2023
营收: NOK0
毛利润: NOK-371 000 (0.00 %)
EPS: NOK-0.540
Q4 2023
营收: NOK0
毛利润: NOK-187 000 (0.00 %)
EPS: NOK-0.230
Q2 2023
营收: NOK0
毛利润: NOK-93 000.00 (0.00 %)
EPS: NOK-0.150
Q1 2023
营收: NOK0
毛利润: NOK-91 000.00 (0.00 %)
EPS: NOK-0.150

Financial Reports:

No articles found.

PCI Biotech Holding ASA

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。